Search Posts

Entrepreneurial Journey of Jim Tananbaum

Jim Tananbaum is famous in the healthcare industry as he significantly invested and built health centres. He attended Yale University where he majored in computer science and electrical engineering. From Harvard School, he received an MBA and masters in medical Science. Jim started his career by founding GelTex Pharmaceuticals which provide drugs in the market for less amount. He sold the company for quite a lump sum which he used to found Theravance (NASDAQ THRX) which collaborates with Theravance Biopharma hence making an annual profit of two billion.

Jim worked at Prospect Venture where he was a managing partner in charge of the operational activities of the business. He also helped in the formation of healthcare services investment practices at Sierra Ventures. Jim Tananbaum is part of other investment plans like Amira Pharmaceuticals which he sold to NYSE, Jazz Pharmaceuticals, Heatherton and Amerigroup. Jim currently founded Foresite Capital in 2011 due to his detailed experience in the healthcare industry. He is, therefore, a health care entrepreneur and is a strategist. He is the Chief Executive Officer at Foresite Capital. Follow Foresite Capital on Twitter.

Jim Tananbaum founded it after finding that the healthcare industry has future leaders who can be grown and exploited to maximise their profitability through network, information and capital supply. Foresite has invested in seventy-seven health care companies. For instance, they have invested in Aimmune Therapeutics, Aerie Pharmaceuticals, and Genomics 10x among others. He uses soft wares that easier his work like big query and tableau that helps put all task in one database and easily retrieved. He has also used Outlook and Salesforce that incorporates all his day in day projects.

Jim Tananbaum is inspired by his love to read, persistence and perseverance lead to his success. In his partnership deals, he believes that complimenting one another and teamwork leads to the development of a good innovation portfolio. As a Foresite CEO, he acquired a partner, Dr Molly, to help in the development of genomic research. Dr Molly has previous records in leadership, and this will see that Foresite has a qualified team to deliver to their customers across the world. Jim has also had recognitions due to his great work. In a report by INC42, he has been listed in the top 100 venture capitalists in the Forbes Midas List. He also carries out charities especially to hospitals to research on solutions to different diseases.